NCT03809611: A reported trial by Novartis Pharmaceuticals
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03809611 |
|---|---|
| Title | A 3-month, Randomized, Placebo-controlled, Double-masked, Multi-center Study to Evaluate the Safety and Efficacy of Topical Ocular UNR844-Cl in Subjects With Presbyopia |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 26, 2019 |
| Completion date | Dec. 16, 2019 |
| Required reporting date | Dec. 15, 2020, midnight |
| Actual reporting date | Sept. 28, 2020 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | None |